Vanguard FTSE Developed Markets Index has a market-cap-weighted portfolio that holds nearly all stocks in the developed international market. Its low fee and expansive portfolio make it one of the more appealing international stock funds available.
Vanguard Developed Markets Index Inv VDVIX
- NAV / 1-Day Return 12.99 / +0.54 %
- Total Assets 204.3 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.170%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 0
- Status Limited
- TTM Yield 2.74%
- Turnover 3%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis VDVIX
Will VDVIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 11.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk AS Class B | 1.75 | 3.6 Bil | Healthcare |
ASML Holding NV | 1.47 | 3.0 Bil | Technology |
Nestle SA | 1.16 | 2.4 Bil | Consumer Defensive |
Samsung Electronics Co Ltd | 1.09 | 2.2 Bil | Technology |
AstraZeneca PLC | 1.08 | 2.2 Bil | Healthcare |
Novartis AG Registered Shares | 1.02 | 2.1 Bil | Healthcare |
SAP SE | 0.99 | 2.0 Bil | Technology |
Roche Holding AG | 0.97 | 2.0 Bil | Healthcare |
Shell PLC | 0.94 | 1.9 Bil | Energy |
Toyota Motor Corp | 0.94 | 1.9 Bil | Consumer Cyclical |